Dr. Kimme Hyrich Discusses Cancer Risk in RA Patients Receiving Anti-TNF Therapies
February 22, 2012
Kimme L. Hyrich, MD, Arthritis Research UK Epidemiology Unit at University of Manchester, discusses the risk of rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy developing solid cancers.
“When they were first used and available for widespread use, there was a continuing anxiety about whether or not an agent which blocks tumor necrosis factor would actually increase the risk of cancer in patients with rheumatoid arthritis,” said Hyrich.
Since pancreatic cancer is so rare, screening among the general population is not worthwhile, according to Randall Brand, MD. Instead, physicians should only screen those individuals considered "high risk."
Brian Schmidt, DDS, MD, PhD, FACS, offers advice for reducing anxiety and depression in oral cancer patients at the American Pain Society (APS) 33rd Annual Scientific Meeting, held April 30, 2014, to May 3, 2014, in Tampa, FL.